» Articles » PMID: 39021627

Circulating Free DNA As a Diagnostic Marker for Echinococcosis: a Systematic Review and Meta-analysis

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2024 Jul 18
PMID 39021627
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Echinococcosis is a chronic zoonotic disease caused by tapeworms of the genus . The World Health Organization (WHO) has identified encapsulated disease as one of 17 neglected diseases to be controlled or eliminated by 2050. There is no accurate, early, non-invasive molecular diagnostic method to detect echinococcosis. The feasibility of circulating free DNA as a diagnostic method for echinococcosis has yielded inconclusive results in a number of published studies. However, there has been no systematic evaluation to date assessing the overall performance of these assays. We report here the first meta-analysis assessing the diagnostic accuracy of cfDNA in plasma, serum, and urine for echinococcosis.

Methods: We systematically searched PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and WeiPu databases up to 17 January 2024, for relevant studies. All analyses were performed using RevMan 5.3, Meta-DiSc 1.4, Stata 17.0, and R 4.3.1 software. The sensitivity, specificity, and other accuracy indicators of circulating free DNA for the diagnosis of echinococcosis were summarized. Subgroup analyses and meta-regression were performed to identify sources of heterogeneity.

Results: A total of 7 studies included 218 patients with echinococcosis and 214 controls (156 healthy controls, 32 other disease controls (non-hydatid patients), and 26 non-study-targeted echinococcosis controls were included). Summary estimates of the diagnostic accuracy of cfDNA in the diagnosis of echinococcosis were as follows: sensitivity (SEN) of 0.51 (95% CI: 0.45-0.56); specificity (SPE) of 0.99 (95% CI: 0.97-0.99); positive likelihood ratio (PLR) of 11.82 (95% CI: 6.74-20.74); negative likelihood ratio (NLR) of 0.57 (95% CI: 0.41-0.80); diagnostic ratio (DOR) of 36.63 (95% CI: 13.75-97.59); and area under the curve (AUC) value of 0.98 (95% CI: 0.96-1.00).

Conclusion: Existing evidence indicates that the combined specificity of circulating cfDNA for echinococcosis is high. However, the combined sensitivity performance is unsatisfactory due to significant inter-study heterogeneity. To strengthen the validity and accuracy of our findings, further large-scale prospective studies are required.Systematic review registrationThe systematic review was registered in the International Prospective Register of Systematic Reviews PROSPERO [CRD42023454158]. https://www.crd.york.ac.uk/PROSPERO/.

References
1.
Deplazes P, Rinaldi L, Alvarez Rojas C, Torgerson P, Harandi M, Romig T . Global Distribution of Alveolar and Cystic Echinococcosis. Adv Parasitol. 2017; 95:315-493. DOI: 10.1016/bs.apar.2016.11.001. View

2.
McManus D, Zhang W, Li J, Bartley P . Echinococcosis. Lancet. 2003; 362(9392):1295-304. DOI: 10.1016/S0140-6736(03)14573-4. View

3.
Bronkhorst A, Ungerer V, Diehl F, Anker P, Dor Y, Fleischhacker M . Towards systematic nomenclature for cell-free DNA. Hum Genet. 2020; 140(4):565-578. PMC: 7981329. DOI: 10.1007/s00439-020-02227-2. View

4.
Torgerson P, Budke C . Echinococcosis--an international public health challenge. Res Vet Sci. 2003; 74(3):191-202. DOI: 10.1016/s0034-5288(03)00006-7. View

5.
Zhao Y, Shen S, Jin X, Wang W, Li J, Chen W . Cell-free DNA as a diagnostic tool for human echinococcosis. Trends Parasitol. 2021; 37(11):943-946. DOI: 10.1016/j.pt.2021.07.006. View